Vote · Roll call
Amendment 379, after Article 40
Union procedures for the authorisation and supervision of medicinal products for human use and rules governing the European Medicines Agency
- Vote
- Amendment 379, after Article 40
- Decision
- No. 32 of the sitting of 10 Apr 2024
- Result
- 156 for · 334 against · 98 abstained Rejected · roll call
- Date
- 10 April 2024, 19:22
More facts (6)
- Position
- vote 36 of 40 on the decision
- Requested by
- roll call: The Left
- Official label
- A9-0141/2024 – Tiemo Wölken – After Article 40 – Am 379
- Text
- Report A-9-2024-0141
- Dossier
- 2023-0131
- Vote id
- 167784
Export
- CSV
- JSON
- Country × group (CSV)
- Country × group (JSON)
- The members file includes members in office who did not vote.
More
The members file includes members in office who did not vote.
Roll-call results (EP) (opens the official site)Result
The vote as recorded by name.
Result: 156 for, 334 against, 98 abstained (roll call).
Rejected · 27 % of the votes cast were for.
Groups
Members counted in their current group: the view with groups at the date of the vote is not available right now.
| Group | For | Against | Abst. | Majority line | Clear line | Bar |
|---|---|---|---|---|---|---|
| S&D | For 14 | Against 3 | Abst. 40 | Majority line Abstained | Clear line Abstained | |
| The Left | For 13 | Against 0 | Abst. 0 | Majority line For | Clear line For | |
| Greens | For 17 | Against 2 | Abst. 6 | Majority line For | Clear line For | |
| Patriots | For 2 | Against 22 | Abst. 2 | Majority line Against | Clear line Against | |
| Renew | For 2 | Against 36 | Abst. 0 | Majority line Against | Clear line Against | |
| No group | For 1 | Against 2 | Abst. 2 | Majority line — | Clear line No line | |
| EPP | For 5 | Against 74 | Abst. 1 | Majority line Against | Clear line Against | |
| ECR | For 1 | Against 24 | Abst. 0 | Majority line Against | Clear line Against | |
| ESN | For 0 | Against 3 | Abst. 1 | Majority line Against | Clear line Against |
Countries × groups
How each country’s members of each group voted.
The breakdown by country is not available right now.
Members
Each member’s recorded position — groups as of today: the view with groups at the date of the vote is not available right now.
No vote recorded
Members in office that day without a recorded position. No vote recorded is not the same as absent: leave, illness or chairing the sitting look the same.
The list of members without a recorded position is not available right now.
Similar votes
Roll calls that split the chamber the most similarly: r is the correlation of members’ positions, over the members who voted in both. Other votes on the same decision are left out.
Similar votes are not available right now.
Compare with another vote
Groups’ lines side by side, and the members who switched between the two votes.
Connections
This vote’s decision, the other votes on it, and related votes.
No connections found for this vote.
Sources & citation
Where the facts on this page come from, and how to cite it.
- Official sources
- Data source
- Licensed CC BY 4.0.
- Retrieved
- 25 September 2026
Cite as
European Parliament (2024). “Amendment 379, after Article 40 — Union procedures for the authorisation and supervision of medicinal products for human use and rules governing the European Medicines Agency”. Vote, 10 April 2024. votingId 167784, reference 2023-0131. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/votes/2024-04-10/167784 (retrieved 25 September 2026). Official sources: Roll-call votes, sitting of 10 April 2024 (European Parliament), https://www.europarl.europa.eu/doceo/document/PV-10-2024-04-10-RCV_EN.html; Results of votes, sitting of 10 April 2024 (European Parliament), https://www.europarl.europa.eu/doceo/document/PV-10-2024-04-10-VOT_EN.html. Data: EP Open Data API: vote results of the sitting MTG-PL-2024-04-10, https://data.europarl.europa.eu/api/v2/meetings/MTG-PL-2024-04-10/vote-results?format=application%2Fld%2Bjson (CC BY 4.0).
BibTeX
@misc{epw-vote-2024-04-10-167784,
author = {{European Parliament}},
title = {{Amendment 379, after Article 40 — Union procedures for the authorisation and supervision of medicinal products for human use and rules governing the European Medicines Agency}},
year = {2024},
date = {2024-04-10},
howpublished = {\url{https://news.eu-parl.st-solutions.dev/votes/2024-04-10/167784}},
url = {https://news.eu-parl.st-solutions.dev/votes/2024-04-10/167784},
urldate = {2026-09-25},
publisher = {EU Parl Watch Research},
note = {Vote. votingId 167784, reference 2023-0131. Official source: https://www.europarl.europa.eu/doceo/document/PV-10-2024-04-10-RCV\_EN.html, https://www.europarl.europa.eu/doceo/document/PV-10-2024-04-10-VOT\_EN.html. Data: EP Open Data API: vote results of the sitting MTG-PL-2024-04-10 (CC BY 4.0)}
}